Answers are grounded in this paper and cite their sources.
To help researchers determine what studies to replicate, Isager et al. (2021, p.1) introduced the Replication Value (RV), “a proxy for expected utility gain”. In this commentary, we point out that there are scenarios where people can opt to replicate studies with a lower RV compared to those with a higher RV. Methodologically, we highlight that the differences in the RV become very small when comparing studies with different large (e.g., over 500) samples. To adjust for this, we demonstrate that a modification to the RV-equation – by log transforming the sample size – leads to a RV that discriminates between studies with large sample sizes with greater precision.
No takes yet. Share an insight, caveat, or question.
Bakker et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: